Year |
Citation |
Score |
2020 |
Keller L, Canuto KM, Liu C, Suzuki BM, Almaliti J, Sikandar A, Naman CB, Glukhov E, Luo D, Duggan BM, Luesch H, Koehnke J, O'Donoghue AJ, Gerwick WH. Tutuilamides A-C: Vinyl-Chloride Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties. Acs Chemical Biology. PMID 31935054 DOI: 10.2210/Pdb6Th7/Pdb |
0.408 |
|
2020 |
Kasabri V, Arabiyat S, Al-Hiari Y, Zalloum H, Almaliti J, Telfah A, Bustanji YK, Alalawi S. Fluoroquinolones as a potentially novel class of antidiabesity and antiproliferative compounds: synthesis and docking studies Canadian Journal of Chemistry. 1-11. DOI: 10.1139/Cjc-2020-0162 |
0.357 |
|
2019 |
Boudreau PD, Miller BW, McCall LI, Almaliti J, Reher R, Hirata K, Le T, Siqueira-Neto JL, Hook VYH, Gerwick WH. Design of gallinamide A analogs as potent inhibitors of the cysteine proteases human cathepsin L and Trypanosoma cruzi cruzain. Journal of Medicinal Chemistry. PMID 31539239 DOI: 10.1021/Acs.Jmedchem.9B00294 |
0.4 |
|
2019 |
O'Donoghue AJ, Bibo-Verdugo B, Miyamoto Y, Wang SC, Yang JZ, Zuill DE, Matsuka S, Jiang Z, Almaliti J, Caffrey CR, Gerwick WH, Eckmann L. 20S proteasome as a drug target in . Antimicrobial Agents and Chemotherapy. PMID 31451503 DOI: 10.1128/Aac.00448-19 |
0.391 |
|
2019 |
Bibo-Verdugo B, Wang SC, Almaliti J, Ta AP, Jiang Z, Wong DA, Lietz CB, Suzuki B, El-Sakkary N, Hook VYH, Salvesen GS, Gerwick WH, Caffrey CR, O'Donoghue AJ. The proteasome as a drug target in the metazoan pathogen, . Acs Infectious Diseases. PMID 31355632 DOI: 10.1021/Acsinfecdis.9B00237 |
0.362 |
|
2019 |
Abutayeh RF, Almaliti J, Taha MO. Design and Synthesis of New Sulfonamides-Based Flt3 Inhibitors. Medicinal Chemistry (Shariqah (United Arab Emirates)). PMID 30931863 DOI: 10.2174/1573406415666190401144053 |
0.311 |
|
2018 |
Almaliti J, Miller B, Pietraszkiewicz H, Glukhov E, Naman CB, Kline T, Hanson J, Li X, Zhou S, Valeriote FA, Gerwick WH. Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agents. European Journal of Medicinal Chemistry. 161: 416-432. PMID 30384045 DOI: 10.1016/J.Ejmech.2018.10.024 |
0.418 |
|
2017 |
Naman CB, Almaliti J, Armstrong L, Caro-Díaz EJ, Pierce ML, Glukhov E, Fenner A, Spadafora C, Debonsi HM, Dorrestein PC, Murray TF, Gerwick WH. Discovery and Synthesis of Caracolamide A, an Ion Channel Modulating Dichlorovinylidene Containing Phenethylamide from a Panamanian Marine Cyanobacterium cf. Symploca Species. Journal of Natural Products. PMID 28783331 DOI: 10.1021/Acs.Jnatprod.7B00367 |
0.394 |
|
2017 |
LaMonte GM, Almaliti J, Bibo-Verdugo B, Keller L, Zou BY, Yang J, Antonova-Koch Y, Orjuela-Sanchez P, Boyle CA, Vigil E, Wang L, Goldgof GM, Gerwick L, O'Donoghue AJ, Winzeler EA, et al. Development of a potent inhibitor of the Plasmodium proteasome with reduced mammalian toxicity. Journal of Medicinal Chemistry. PMID 28696697 DOI: 10.1021/Acs.Jmedchem.7B00671 |
0.448 |
|
2017 |
Almaliti J, Malloy KL, Glukhov E, Spadafora C, Gutiérrez M, Gerwick WH. Dudawalamides A-D, Antiparasitic Cyclic Depsipeptides from the Marine Cyanobacterium Moorea producens. Journal of Natural Products. PMID 28535042 DOI: 10.1021/Acs.Jnatprod.7B00034 |
0.322 |
|
2016 |
Almaliti J, Al-Hamashi AA, Negmeldin AT, Hanigan CL, Perera L, Pflum MK, Casero RA, Tillekeratne LM. Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue. Journal of Medicinal Chemistry. PMID 27809521 DOI: 10.1021/Acs.Jmedchem.6B01271 |
0.547 |
|
2016 |
Paatero AO, Kellosalo J, Dunyak BM, Almaliti J, Gestwicki JE, Gerwick WH, Taunton J, Paavilainen VO. Apratoxin Kills Cells by Direct Blockade of the Sec61 Protein Translocation Channel. Cell Chemical Biology. 23: 561-6. PMID 27203376 DOI: 10.1016/J.Chembiol.2016.04.008 |
0.344 |
|
2013 |
Almaliti J, Nada SE, Carter B, Shah ZA, Tillekeratne LM. Natural products inspired synthesis of neuroprotective agents against Hâ‚‚Oâ‚‚-induced cell death. Bioorganic & Medicinal Chemistry Letters. 23: 1232-7. PMID 23380377 DOI: 10.1016/J.Bmcl.2013.01.013 |
0.536 |
|
Show low-probability matches. |